Novo vs. KBP: How a $1.3B deal turned into an international legal fight
gold coins and bars
Biotech

Takeda strikes Innovent pact worth up to $11.4B

The deal, which includes $10.2 billion in milestones, puts the biologics at the center of Takeda’s efforts to establish new growth drivers.
Nick Paul Taylor Oct 22, 2025 9:15am
Bringing clinical trials to the community a new model for precision enrollment

Bringing clinical trials to the community: a new model for precision enrollment

Oct 20, 2025 8:00am
On target clinical trial success bullseye score

Sanofi's $1.7B bet beats CSL's Zemaira in phase 2 face-off

Oct 22, 2025 10:35am
Redefining Biotech How AI and Real-World Data Power Patient-Centered Progress

Redefining Biotech: AI, RWD, and Patient-Centered Progress

Oct 20, 2025 8:00am
brain

Alector halves staff after GSK-partnered antibody fails in ph. 3

Oct 22, 2025 11:23am
Launch

Psychiatrist launches new CRO with patient-centered focus

Oct 22, 2025 2:22pm
More News

Arcturus’ stock halves on cystic fibrosis readout

Oct 22, 2025 1:01pm
Fierce Healthcare

Government shutdown updates: CMS lifts PFS claims hold

Oct 22, 2025 11:30am

Ipsen inks €1B buyout of French biotech ImCheck

Oct 22, 2025 10:33am

Fierce Biotech Layoff Tracker 2025: Alector, Galapagos & more

Oct 22, 2025 9:00am